Linaclotide acetate: Phase IIb completed

In a double-blind, placebo-controlled, dose-escalating, U.S. and Canadian Phase IIb trial in 419 patients with IBS-C, all 4 doses of linaclotide met the primary endpoint of change in CSBM frequency vs...